243 related articles for article (PubMed ID: 35211843)
1. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y
Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843
[TBL] [Abstract][Full Text] [Related]
2. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota.
Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X
J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989
[TBL] [Abstract][Full Text] [Related]
3. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
4. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
Song Y; Lau HC; Zhang X; Yu J
Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.
Singh V; Yeoh BS; Abokor AA; Golonka RM; Tian Y; Patterson AD; Joe B; Heikenwalder M; Vijay-Kumar M
Gut Microbes; 2020 Jul; 11(4):1077-1091. PubMed ID: 32223398
[TBL] [Abstract][Full Text] [Related]
7. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
[TBL] [Abstract][Full Text] [Related]
8. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
9. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
Sitkin S; Pokrotnieks J
Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
[TBL] [Abstract][Full Text] [Related]
10. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota.
Jin D; Huang K; Xu M; Hua H; Ye F; Yan J; Zhang G; Wang Y
Gut Microbes; 2022; 14(1):2120744. PubMed ID: 36067404
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury.
Zhang L; Zheng Z; Huang H; Fu Y; Chen T; Liu C; Yi Q; Lin C; Zeng Y; Ou Q; Zeng Y
Gut Microbes; 2024; 16(1):2323236. PubMed ID: 38416424
[TBL] [Abstract][Full Text] [Related]
13. Bile salt hydrolase acyltransferase activity expands bile acid diversity.
Guzior DV; Okros M; Shivel M; Armwald B; Bridges C; Fu Y; Martin C; Schilmiller AL; Miller WM; Ziegler KM; Sims MD; Maddens ME; Graham SF; Hausinger RP; Quinn RA
Nature; 2024 Feb; 626(8000):852-858. PubMed ID: 38326608
[TBL] [Abstract][Full Text] [Related]
14. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
15. Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.
Yamada S; Takashina Y; Watanabe M; Nagamine R; Saito Y; Kamada N; Saito H
Oncotarget; 2018 Feb; 9(11):9925-9939. PubMed ID: 29515780
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
[TBL] [Abstract][Full Text] [Related]
17. A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases.
Adhikari AA; Ramachandran D; Chaudhari SN; Powell CE; Li W; McCurry MD; Banks AS; Devlin AS
ACS Chem Biol; 2021 Aug; 16(8):1401-1412. PubMed ID: 34279901
[TBL] [Abstract][Full Text] [Related]
18. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
[TBL] [Abstract][Full Text] [Related]
20. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial.
Wan Y; Yuan J; Li J; Li H; Zhang J; Tang J; Ni Y; Huang T; Wang F; Zhao F; Li D
Clin Nutr; 2020 Feb; 39(2):395-404. PubMed ID: 30876827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
